Literature DB >> 17912586

Outcome after hepatic resection of solitary liver metastasis from colorectal cancer in the caudate lobe.

Akio Saiura1, Junji Yamamoto, Rintaro Koga, Norihiro Kokudo, Makoto Seki, Masatoshi Oya, Masashi Ueno, Hiroya Kuroyanagi, Yoshiya Fujimoto, Takeshi Natori, Toshiharu Yamaguchi, Tetsuichiro Muto.   

Abstract

BACKGROUND: The prognosis of solitary liver metastasis involving the caudate lobe is unclear. This study analyzed the outcomes after resection of the caudate lobe for solitary colorectal liver metastasis.
METHODS: We reviewed the records of 114 cases in which potentially curative hepatectomy were performed for solitary colorectal liver metastasis. Solitary liver metastasis involving the caudate lobe was seen in 14 cases (Caudate group). The outcomes were compared with those of the remaining 100 cases with metastasis in a site other than the caudate lobe (Other group).
RESULTS: No hospital deaths occurred. The 5-year survival rate for all cases was 61%. Recurrence-free and cumulative survivals were similar in the two groups, as were the intraoperative blood loss, duration of operation, and postoperative hospital stay. The distance of the surgical margin was significantly shorter in the Caudate group than in the Other group (0.6 mm vs. 6.6 mm; p = 0.001). A concomitant resection of the inferior vena cava was performed in four patients in the Caudate group but in no patients in the Other group (p < 0.001).
CONCLUSIONS: Despite a minimal surgical margin, the resection of solitary colorectal liver metastasis offers favorable short- and long-term outcomes comparable to those for colorectal liver metastasis at other sites.

Entities:  

Mesh:

Year:  2007        PMID: 17912586     DOI: 10.1007/s00268-007-9250-9

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.282


  20 in total

1.  Surgical outcome of solitary colorectal metastasis to the hepatic caudate lobe.

Authors:  K Tanaka; H Shimada; K Matsuo; Y Nagano; S Togo
Journal:  Br J Surg       Date:  2005-07       Impact factor: 6.939

2.  Surgical outcomes of isolated caudate lobe resection: a single series of 19 patients.

Authors:  Juan M Sarmiento; Florencia G Que; David M Nagorney
Journal:  Surgery       Date:  2002-10       Impact factor: 3.982

3.  Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome.

Authors:  B Cady; R L Jenkins; G D Steele; W D Lewis; M D Stone; W V McDermott; J M Jessup; A Bothe; P Lalor; E J Lovett; P Lavin; D C Linehan
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

4.  Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results.

Authors:  M Minagawa; M Makuuchi; G Torzilli; T Takayama; S Kawasaki; T Kosuge; J Yamamoto; H Imamura
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

5.  Pattern of recurrence in liver resection for colorectal secondaries.

Authors:  H Ekberg; K G Tranberg; R Andersson; C Lundstedt; I Hägerstrand; J Ranstam; S Bengmark
Journal:  World J Surg       Date:  1987-08       Impact factor: 3.352

6.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Authors:  Y Fong; J Fortner; R L Sun; M F Brennan; L H Blumgart
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

7.  Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of patterns of recurrence.

Authors:  K S Hughes; R Simon; S Songhorabodi; M A Adson; D M Ilstrup; J G Fortner; B J Maclean; J H Foster; J M Daly; D Fitzherbert
Journal:  Surgery       Date:  1986-08       Impact factor: 3.982

8.  The natural history of hepatic metastases from colorectal cancer. A comparison with resective treatment.

Authors:  J S Wagner; M A Adson; J A Van Heerden; M H Adson; D M Ilstrup
Journal:  Ann Surg       Date:  1984-05       Impact factor: 12.969

Review 9.  Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer.

Authors:  Herbert Hurwitz
Journal:  Clin Colorectal Cancer       Date:  2004-10       Impact factor: 4.481

10.  Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer.

Authors:  David Cunningham; Yves Humblet; Salvatore Siena; David Khayat; Harry Bleiberg; Armando Santoro; Danny Bets; Matthias Mueser; Andreas Harstrick; Chris Verslype; Ian Chau; Eric Van Cutsem
Journal:  N Engl J Med       Date:  2004-07-22       Impact factor: 91.245

View more
  1 in total

1.  Analysis of prognostic factors after resection of solitary liver metastasis in colorectal cancer: a 22-year bicentre study.

Authors:  Sara Acciuffi; Frank Meyer; Astrid Bauschke; Utz Settmacher; Hans Lippert; Roland Croner; Annelore Altendorf-Hofmann
Journal:  J Cancer Res Clin Oncol       Date:  2018-01-16       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.